• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Model Number D134805
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Cardiac Arrest (1762); Vasoconstriction (2126); Embolism/Embolus (4438)
Event Date 03/01/2023
Event Type  Injury  
Manufacturer Narrative
Initial reporter phone: (b)(6).The device has been reported as discarded, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation was performed for the finished device: 30927997l number, and no internal action related to the complaint was found during the review.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
 
Event Description
It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter (stsf) and suffered cardiac arrest and arterial spasm requiring prolonged hospitalization.It was reported that after the procedure, there was pericardial effusion (pe) confirmed on the body surface echography.Electrocardiogram showed st elevation, and coronary artery spasm was also confirmed.After extubating by the anesthesiology department, both blood pressure and spo2 became unmeasurable, and cardiac arrest was confirmed because the heart was not beating when fluoroscopy was performed.Initial waveform pea.Timing when complaints occurred was 30 minutes after the procedure, after extubating.Resuscitation was performed, and rosc (return of spontaneous circulation).Spontaneous breathing and eye opening were observed.The patient is being follow-up.Atrial septal puncture was performed.Ablation was performed before pericardial effusion was identified.There was no evidence of steam pop.Irrigation catheter¿s flow rate setting: stsf was used, and the flow rate was set as specified.There were no abnormalities observed prior to and during use of the product.Extended hospitalization was required.The physician provided the correct information that ¿no pericardial effusion was observed with the surface echography in which performing by routine after the procedure¿.The st elevation and cardiac arrest occurred with awakening from anesthesia.Coronary angiography after the introduction of pcps showed coronary spasm, so coronary artery was dilated using a vasodilator, and then autologous pulse was resumed.The adverse event occurred on (b)(6) 2023.It was discovered post use of biosense webster products.The physician¿s opinion on the cause of this adverse event was that there was no perforation by catheter.It was unknown whether the coronary spasm was due to ablation or not.Patient required extended hospitalization because of the adverse event.Other relevant history --- interstitial pneumonia, ef 30%, rheumatoid arthritis.Force visualization features used were real time graph; dashboard; vector.Additional filter used with the visitag was fot.Tag index was used.Transseptal puncture was performed.Stsf was used, and the flow rate was set as specified.
 
Manufacturer Narrative
Additional information was received on 30-mar-2023.It was reported that the physician considered that the adverse event occurred due to the patient condition but the actual cause was unknown.The intervention provided was the administration of vasodilators, heart massage, and tracheal intubation.The patient was followed-up in the intensive care unit (icu).While following up, the patient developed a cerebral embolism.We tried, but we could not obtain the information about the treatment for a cerebral embolism.The patient was still in the hospital and the condition was improving.Since the patient developed a cerebral embolism, the patient was going to be transferred to a rehabilitation hospital.The h6.Health effect - clinical code was updated and code embolism/embolus (e0503) was added.A smartablate generator was used.A visitag module was used and the parameters for stability were 3mm, 3sec.A radiofrequency (rf) needle was used.The correct catheter settings were selected on the generator.The pump was switching from ¿low¿ to ¿high¿ flow during ablation.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMOCOOL® SMART TOUCH® SF BI-DIRECTIONAL NAVIGATION CATHETER
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key16637128
MDR Text Key312237058
Report Number2029046-2023-00671
Device Sequence Number1
Product Code LPB
UDI-Device Identifier10846835010183
UDI-Public10846835010183
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P030031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/29/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberD134805
Device Catalogue NumberD134805
Device Lot Number30927997L
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/30/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/12/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
UNK BRAND TRANSSEPTAL NEEDLE.; UNK_CARTO 3.
Patient Outcome(s) Required Intervention; Hospitalization; Life Threatening;
Patient Age73 YR
Patient SexMale
Patient Weight76 KG
-
-